Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesGains from Investment SecuritiesNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Depreciation & Amortization (CF): 2020-2022

Historic Depreciation & Amortization (CF) for Pharming Group N.V (PHAR) over the last 2 years, with Dec 2022 value amounting to $2.2 million.

  • Pharming Group N.V's Depreciation & Amortization (CF) rose 6.16% to $2.2 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.2 million, marking a year-over-year increase of 6.10%. This contributed to the annual value of $19,567 for FY2021, which is 99.76% down from last year.
  • Latest data reveals that Pharming Group N.V reported Depreciation & Amortization (CF) of $2.2 million as of Q4 2022, which was up 151.45% from -$4.3 million recorded in Q3 2022.
  • Pharming Group N.V's 5-year Depreciation & Amortization (CF) high stood at $4.5 million for Q2 2021, and its period low was -$4.5 million during Q3 2021.
  • In the last 3 years, Pharming Group N.V's Depreciation & Amortization (CF) had a median value of $2.1 million in 2022 and averaged $914,020.
  • Per our database at Business Quant, Pharming Group N.V's Depreciation & Amortization (CF) tumbled by 296.04% in 2021 and then spiked by 106,056.08% in 2022.
  • Pharming Group N.V's Depreciation & Amortization (CF) (Quarterly) stood at $2.6 million in 2020, then fell by 19.82% to $2.1 million in 2021, then climbed by 6.16% to $2.2 million in 2022.
  • Its Depreciation & Amortization (CF) stands at $2.2 million for Q4 2022, versus -$4.3 million for Q3 2022 and $2.1 million for Q2 2022.